Increased serum proMMP-3 in inflammatory arthritides: a potential indicator of synovial inflammatory monokine activity.
about
Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatmentThe co-expression of activating and inhibitory leukocyte immunoglobulin-like receptors in rheumatoid synovium.Long term anti-tumour necrosis factor alpha monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation.Simvastatin reduces MMP-3 level in interleukin 1beta stimulated human chondrocyte culturePannocytes: distinctive cells found in rheumatoid arthritis articular cartilage erosions.Pravastatin suppresses matrix metalloproteinase expression and activity in human articular chondrocytes stimulated by interleukin-1βAlteration of matrix metalloproteinase-3 O-glycan structure as a biomarker for disease activity of rheumatoid arthritis.Role of matrix metalloproteinase-3 (MMP-3) and magnetic resonance imaging of sacroiliitis in assessing disease activity in ankylosing spondylitis.Change in cellular localization of a rheumatoid arthritis-related antigen (RA-A47) with downregulation upon stimulation by inflammatory cytokines in chondrocytes.Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis.Prostaglandins increase proMMP-1 and proMMP-3 secretion by human ciliary smooth muscle cells.Reduction of interleukin-1β induced matrix metalloproteinase-3 release by extracts of six plants: inhibitory screening of 35 traditional medicinal plants.Changes in biochemical markers of joint tissue metabolism in a randomized controlled trial of glucocorticoid in early rheumatoid arthritis.
P2860
Q28345197-A39A4CC0-B5A4-4081-B796-D32789685A17Q30673087-A0CB2640-B6F6-4E67-A620-6FAB64B7448BQ35551481-BF310EE2-36E5-47F3-97E4-D69CEC3FAAB0Q35554255-496A09D4-F1EE-4EEF-8412-BF7A71D09D9DQ35763598-9F327A8F-C859-4D59-A05D-D67181CF3424Q36189250-15566AE2-0050-424E-9E57-21CC0E3BAB4BQ36923243-2B20CA6E-AC8D-4043-805F-062A9D0B0C64Q39476642-76571F9F-492B-4CB8-9906-1BFAACE1DDCBQ40828665-5252CB0C-5FB4-4017-8D0C-648E7185C5A7Q42616855-A8B6A78E-2814-4614-9147-5C08F998CA58Q46096320-A648B9FC-96E1-45E0-9578-739026F87A3EQ47327531-3D50F14A-0041-4468-AFDB-6D105E5CF931Q47849262-3C78A5D7-122B-4239-8295-21990EFE7F74
P2860
Increased serum proMMP-3 in inflammatory arthritides: a potential indicator of synovial inflammatory monokine activity.
description
1994 nî lūn-bûn
@nan
1994 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Increased serum proMMP-3 in in ...... nflammatory monokine activity.
@ast
Increased serum proMMP-3 in in ...... nflammatory monokine activity.
@en
Increased serum proMMP-3 in in ...... nflammatory monokine activity.
@nl
type
label
Increased serum proMMP-3 in in ...... nflammatory monokine activity.
@ast
Increased serum proMMP-3 in in ...... nflammatory monokine activity.
@en
Increased serum proMMP-3 in in ...... nflammatory monokine activity.
@nl
prefLabel
Increased serum proMMP-3 in in ...... nflammatory monokine activity.
@ast
Increased serum proMMP-3 in in ...... nflammatory monokine activity.
@en
Increased serum proMMP-3 in in ...... nflammatory monokine activity.
@nl
P2093
P2860
P356
P1476
Increased serum proMMP-3 in in ...... nflammatory monokine activity.
@en
P2093
P2860
P304
P356
10.1136/ARD.53.11.768
P407
P577
1994-11-01T00:00:00Z